MedTrace Logo

Specimen and Data Collection in South Carolina Medicaid-Enrolled Patients With Type 2 Diabetes (T2D) and Metabolically Healthy Controls

NCT07731399 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2026-08-18

No results posted yet for this study

Summary

The primary purpose of this study is to use multiomic data in combination with clinical assessments, electronic health records, cognitive and mood assessments, wearable technologies and lifestyle/behavioral data to identify data elements or combinations of data elements with strong positive or negative correlation to CKD diagnosis and/or progression in Type 2 Diabetes (T2D) patients. Achieving this aim will allow researchers and physicians to significantly improve the prediction of health trajectories of and formulate novel strategies to potentially prevent, treat or reverse T2D. South Carolina Medicaid-enrolled patients diagnosed with T2D and a smaller subset of non-T2D SC Medicaid patients may participate in this study. Participants who complete required procedures will be compensated for their time and transportation, may keep their study-provided Fitbit device to help maintain their healthcare improvement journey, and will have a personal Certified Diabetes Educator to consult and assist with managing their diabetes diagnosis.

Conditions

Interventions

OTHER

Not applicable- observational study

Non-interventional biospecimen and data collection study.

Sponsors & Collaborators

  • South Carolina Department of Health and Human Services

    collaborator UNKNOWN

  • Spartanburg Regional Healthcare System

    collaborator OTHER

  • Guardian Research Network, Inc.

    lead OTHER

Principal Investigators

  • Randy Axelrod, MD · Guardian Research Network, Inc.

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2029-08-31
Completion
2029-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07731399 on ClinicalTrials.gov